Table 4. HBeAg/anti-HBe status, viral load and precore/core mutations of Angolan subjects (completely sequenced HBV isolates).
| Mutations | ||||
| Samples | HBeAg/antiHBe status | Viral load (log copies/ml) | Basal core promoter | Precore |
| Concurrent HBsAg and anti-HBs | ||||
| LDA072 | Pos/Neg | 6.37 | – | G1896A |
| LDA265 | Pos/Neg | 6.24 | A1762T/G1764A | – |
| LDA277 | Pos/Neg | 8.25 | – | – |
| LDA278 | Neg/Neg | 5.33 | – | – |
| LDA423 | Neg/Pos | 4.46 | A1762T/G1764A | G1896A, G1899A |
| HBsAg without anti-HBs | ||||
| LDA154 | Pos/Neg | 9.50 | – | – |
| LDA173 | Pos/Neg | 7.45 | – | – |
| LDA274 | Neg/Pos | 4.49 | – | G1896A, G1899A |
| LDA379 | Pos/Neg | 8.71 | – | – |
| LDA386 | Pos/Neg | 8.90 | – | – |
| LDA399 | Neg/Pos | 4.52 | A1762/G1764A | – |
| LDA417 | Neg/Pos | 5.04 | – | G1896A |
| LDA439 | Pos/Neg | 7.40 | – | – |
| LDA445 | Pos/Neg | 5.11 | – | – |
| LDA405 | Neg/Neg | 5.01 | – | – |
| LDA504 | Pos/Neg | 4.30 | – | – |